If the scalp is involved as part of severe psoriasis deemed too extensive to be treated practically with topical medications, then medications delivered orally or by injection may be necessary. All these medications comprise more risk when compared to topical medication. They include oral drugs like methotrexate ( Rheumatrex , Trexall ), cyclosporine ( Sandimmune ), acitretin ( Soriatane ), apremilast ( Otezla ), and some of the so-called biological drugs that are administered by infusion into a vein ( infliximab [ Remicade ]) or by injection into the deeper layers of the skin like etanercept ( Enbrel ), adalimumab ( Humira ), ustekinumab ( Stelara ), secukinumab (Cosentyx), and ixekizumab (Taltz). Regular laboratory work may be necessary to monitor for the toxicities associated with some of these systemic therapies.
FDA. “FDA approves Amjevita, a biosimilar to Humira.”
Kurd, . Journal of the American Academy of Dermatology , April 2008.
National Cancer Institute: "Dictionary of Cancer Terms: Turmeric."
National Psoriasis Foundation: "Complementary approaches: natural elements." "Over-the-counter (OTC) Topicals."
University of Maryland Medical Center: "Psoriasis -- Treatment."
University of Michigan Health System: "Psoriasis Topic Overview."
University of Maryland Medical Center: "Aloe."
University of Michigan Health System: "Psoriasis."
We will take a detailed history, examine your skin and then clearly explain the treatment protocol and any individually prescribed topical and nutritional medications that are recommended for you. We assess every patient's skin needs on an individual basis to develop a customised programme rather than take a one-size-fits-all approach.
With respect to eczema, dermatitis and rosacea, there can be a wide range of variation between the topical and nutritional preparations prescribed from one individual to the next. In comparison, whilst psoriasis and acne represent two very different skin conditions, in both cases, there is more uniformity across individual sufferers with regard to response to topical preparations and internal supplementation requirements. You will generally be reviewed after two weeks and in most cases we would expect a clear reduction in signs and symptoms of your skin condition. In the majority of cases, you will be reviewed on a monthly basis for approximately three months until your skin condition is resolved or significantly reduced. Throughout the period of treatment, we make individual adjustments in your prescription medicines, to achieve the best result for you, naturally!